Ochre Bio’s $37.5 Million License Agreement with GSK

Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction.Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a multi-year…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now